Goldman Sachs tips ResMed shares to rocket 30% to a record high
The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...
3 growing ASX dividend stocks to buy in January
These ASX dividend stocks are being tipped to deliver a growing income stream by brokers. Here's what you need to ...